Zobrazeno 1 - 10
of 16
pro vyhledávání: '"K. A. Dugi"'
Publikováno v:
Journal of Lipid Research, Vol 38, Iss 9, Pp 1822-1832 (1997)
In order to evaluate the coordinate role that hepatic lipase (HL) and lecithin:cholesterol acyltransferase (LCAT) play in modulating HDL particle heterogeneity and function in vivo we utilized recombinant adenovirus to express HL in control and LCAT
Externí odkaz:
https://doaj.org/article/056c9c361c5c4141b003f30aefc40f69
Publikováno v:
Journal of Lipid Research, Vol 37, Iss 3, Pp 651-661 (1996)
Familial lipoprotein lipase (LPL) deficiency is an inherited disorder of lipoprotein metabolism characterized by hypertriglyceridemia and recurrent episodes of abdominal pain and pancreatitis. We have studied the genetic basis of LPL deficiency in a
Externí odkaz:
https://doaj.org/article/f3b3c559415b4b72ad34c68b0b2b62d5
Publikováno v:
Journal of Lipid Research, Vol 37, Iss 6, Pp 1213-1223 (1996)
We have identified the underlying molecular defect in a patient with hepatic lipase (HL) deficiency presenting with hypertriglyceridemia and premature cardiovascular disease. DNA sequencing of polymerase chain reaction (PCR) amplified DNA and digesti
Externí odkaz:
https://doaj.org/article/93f7be2605b94c4b8fee833f0c074dbb
Autor:
P S, Wild, T, Zeller, M, Beutel, M, Blettner, K A, Dugi, K J, Lackner, N, Pfeiffer, T, Münzel, S, Blankenberg
Publikováno v:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 55(6-7)
The Gutenberg Health Study is a population-based, prospective, single-center cohort study that started in 2007 at the University Medical Center Mainz. The project focuses on cardiovascular diseases, cancer, eye diseases, metabolic diseases, diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e194384e3030d02a9fd85bb00cd73a87
https://pubmed.ncbi.nlm.nih.gov/22736163
https://pubmed.ncbi.nlm.nih.gov/22736163
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 28(11)
To examine the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in persons with Type 2 diabetes mellitus inadequately controlled [HbA(1c) 53-86 mmol/mol (7.0-10.0%)] by metformin and sulphonylurea combination treatment.A multi-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afd623f10a8674e984a959de2bc751f8
https://pubmed.ncbi.nlm.nih.gov/22587735
https://pubmed.ncbi.nlm.nih.gov/22587735
Autor:
T, Forst, B, Uhlig-Laske, A, Ring, U, Graefe-Mody, C, Friedrich, K, Herbach, H-J, Woerle, K A, Dugi
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 27(12)
The efficacy and safety of the dipeptidyl peptidase-4 inhibitor, linagliptin, added to ongoing metformin therapy, were assessed in patients with Type 2 diabetes who had inadequate glycaemic control (HbA(1c) ≥ 7.5 to ≤ 10%; ≥ 58.5 to ≤ 85.8 mm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::74e87ba1caef990f873790c722d58999
https://pubmed.ncbi.nlm.nih.gov/21059094
https://pubmed.ncbi.nlm.nih.gov/21059094
Autor:
M J, Amar, K A, Dugi, C C, Haudenschild, R D, Shamburek, B, Foger, M, Chase, A, Bensadoun, R F, Hoyt, H B, Brewer, S, Santamarina-Fojo
Publikováno v:
Journal of lipid research. 39(12)
We have investigated the role of hepatic lipase (HL) in remnant lipoprotein metabolism independent of lipolysis by using recombinant adenovirus to express native and catalytically inactive HL (HL-145G) in apolipoprotein (apo)E-deficient mice characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24747e6078a5b58fbb470761989ee5fe
https://pubmed.ncbi.nlm.nih.gov/9831632
https://pubmed.ncbi.nlm.nih.gov/9831632
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 17(7)
Abstract We have studied the underlying molecular defect in a patient presenting with recurrent pancreatitis, hypertriglyceridemia, and virtually undetectable postheparin plasma lipoprotein lipase (LPL) mass and activity, who normalized her triglycer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e9d1b04a629de359290825b23b2028a
https://pubmed.ncbi.nlm.nih.gov/9261273
https://pubmed.ncbi.nlm.nih.gov/9261273
Autor:
J, Kobayashi, D, Applebaum-Bowden, K A, Dugi, D R, Brown, V S, Kashyap, C, Parrott, C, Duarte, N, Maeda, S, Santamarina-Fojo
Publikováno v:
The Journal of biological chemistry. 271(42)
Hepatic lipase (HL) and lipoprotein lipase (LPL) are key enzymes involved in the hydrolysis of triglycerides and phospholipids present in circulating plasma lipoproteins. Despite their similarities, the role that each of these two lipases play in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e3801a5110378e49acc9204d25dd743
https://pubmed.ncbi.nlm.nih.gov/8824281
https://pubmed.ncbi.nlm.nih.gov/8824281
Publikováno v:
Journal of lipid research. 37(6)
We have identified the underlying molecular defect in a patient with hepatic lipase (HL) deficiency presenting with hypertriglyceridemia and premature cardiovascular disease. DNA sequencing of polymerase chain reaction (PCR) amplified DNA and digesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66de405f68c36d952095bbe6107f1d7f
https://pubmed.ncbi.nlm.nih.gov/8808756
https://pubmed.ncbi.nlm.nih.gov/8808756